The Evolving Science of Shock Recognition and Management

Wednesday, July 22, 2020 4:00 – 5:30 p.m. EDT


 
Developed from ISHLT2020 SESSION 02 (SYMPOSIUM)

This session aims to review the evolving understanding of cardiogenic shock, including its varied presentations and trajectories, the importance of hemodynamic data in management, determination of treatment options, and the rapidly growing concept of multidisciplinary shock teams to deliver expedited and patient-centered care.
 

Scientific Program

Moderators: Shelley Hall, MD, FACC, FHFSA, FAST and Peter MacDonald, MD, PhD

Welcome
Kiran Khush, MD, Stanford University, Stanford, CA, USA
Liaison, ISHLT 2020 Program Committee Heart Group

Program Panel Introduction
Shelley Hall, MD, FACC, FHFSA, FAST, Baylor University Medical Center, Dallas, TX, USA
Peter MacDonald, MD, PhD, St. Vincent's Hospital, Sydney, Australia

From Code STEMI to Code Shock: Early Recognition is Key
Anique Ducharme, MD, MSC, Montreal Heart Institute, Montreal, QC, Canada

This talk will review the various phenotypes of cardiogenic shock and the new proposed shock categorization system. The importance of hemodynamics in shock recognition and treatment decision making will also be covered.

Let the Tissue Breathe: Use of Biomarkers to Optimize Organ Perfusion
Sandra V. Chaparro, MD, Miami Cardiac and Vascular Institute / Baptist Health South Florida, Miami, FL, USA

This talk reviews the best way to guide shock management from the blood-based biomarker point of view, in order to guide resuscitation strategies. This will include discussion of the comprehensive metabolic panel, lactate, troponin, and venous blood gas.

Drug Therapy for Cardiogenic Shock: Which, When, and How
Douglas Greig, MD, Pontificia Universidad Católica de Chile, Santiago, Chile

The evidence for medical therapies as the initial basis for management of cardiogenic shock will be presented.

Teamwork Makes the Dream Work: Evolution of the Shock Team
Sharon Chih, MD, University of Ottawa Heart Institute, Ottawa, ON, Canada

This talk will discuss the development of shock teams, the structure of various programs, and their efficacy. The speaker will review tips and recommendations for best practices. How to choose the proper device for support within the shock team collaborative concept will also be covered.

Moderated Q & A
Shelley Hall, MD, FACC, FHFSA, FAST, Baylor University Medical Center, Dallas, TX, USA
Peter MacDonald, MD, PhD, St. Vincent's Hospital, Darlinghurst, New South Sales, Australia
 

Continuing Education Information

Learning Objectives – at the conclusion of this session, attendees will be able to discuss:
  • Review the evolving understanding of cardiogenic shock
  • Discuss thee importance of hemodynamic data in management
  • Discuss determination of treatment options
  • Discuss the rapidly growing concept of multidisciplinary shock teams to deliver expedited and patient-centered care
     
Target Audience – The target audience includes physicians, surgeons, scientists, pharmacists, nurses, transplant coordinators and other allied health and social science professionals engaged in the management and treatment of patients with advanced heart or lung disease, basic science or clinical research related to these fields, or other specialties which cause them to become involved in the treatment of patients with advanced heart or lung disease.

Activity Designed to Change – This activity is designed to change knowledge, competence and performance.

Learning Attributes   Patient Care and Medical Knowledge

Disclosures – Current guidelines state that participants in continuing medical and allied health professional education activities must be made aware of any affiliation or financial interest that may affect the program content or a speaker’s presentation. Planners, Faculty and Chairs participating in this meeting are required to disclose to the program audience any real or apparent conflict(s) of interest related to the content of their presentation or service as Chair/Planner. Disclosures will be distributed in the Learner Notification that you receive as a participant prior to the live virtual session. Additionally, all speakers have been asked to verbally disclose at the start of their presentation any financial interest or affiliations and to indicate if a product they are discussing is not labeled for the use under discussion or is still investigational.

Disclaimer – The information presented in this activity represents the opinion of the faculty and is not necessarily the official position of the ISHLT.

Documenting CME Credits – The ISHLT provides CME certificates to those who have participated in an ISHLT educational activity. The ISHLT does not submit credits to regulating bodies or certifying organizations on behalf of the participants. It is the participants responsibility to submit proof of credits on his or her own behalf.
 

ACCME Accreditation

Physicians

Accreditation Statement - The International Society for Heart and Lung Transplantation (ISHLT) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement – ISHLT designates this live virtual activity for a maximum of 1.5 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses and Pharmacists

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and The International Society for Heart and Lung Transplantation (ISHLT). Amedco LLC is jointly accredited by the American Council for Continuing Medical Education (ACCME) the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation Statement – Amedco LLC designates this live activity for a maximum of 1.5 contact hours for nurses.

Amedco LLC has submitted an application to the Accreditation Council for Pharmacy Education (ACPE) for continuing education credits for this activity.

Nurse Practitioners

The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education.

Transplant Coordinators Credit

An application has been submitted to the American Board for Transplant Certification for Continuing Education Points for this offering.
 
-->